Kodiak Sciences Inc.
KODNasdaqCIK 1468748HealthcareFiscal year ends Dec 31
All transactions: 10
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-23 | Yang TaiyinDirector | Option exercise | 20,000 | $2.35 | $47.0k | Form 4 |
| 2026-10-21 | Borgeson John A.Chief Financial Officer, Officer | Sale | 100 | $94.91 | $9.5k | Form 4 |
| 2026-10-21 | Borgeson John A.Chief Financial Officer, Officer | Sale | 2,000 | $93.71 | $187.4k | Form 4 |
| 2026-10-21 | Borgeson John A.Chief Financial Officer, Officer | Sale | 2,000 | $92.66 | $185.3k | Form 4 |
| 2026-10-21 | Borgeson John A.Chief Financial Officer, Officer | Sale | 2,985 | $91.76 | $273.9k | Form 4 |
| 2026-10-21 | Borgeson John A.Chief Financial Officer, Officer | Sale | 5,101 | $90.98 | $464.1k | Form 4 |
| 2026-10-21 | Borgeson John A.Chief Financial Officer, Officer | Sale | 7,623 | $89.74 | $684.1k | Form 4 |
| 2026-10-21 | Borgeson John A.Chief Financial Officer, Officer | Sale | 1,677 | $89.20 | $149.6k | Form 4 |
| 2026-10-21 | Borgeson John A.Chief Financial Officer, Officer | Sale | 8,514 | $87.67 | $746.4k | Form 4 |
| 2026-10-21 | Borgeson John A.Chief Financial Officer, Officer | Option exercise | 30,000 | $2.49 | $74.7k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 26, 2026, 17:02 ET. Listed shows no prices and gives no investment advice.